Early Introduction of SGLT-2 Inhibitors to Improve Chronic Kidney Disease Care in People with or without Diabetes—Consensus by Indian Nephrologists
Introduction: Chronic kidney disease (CKD) is a progressive condition characterized by reduced kidney function, leading to increased morbidity and mortality. The risk of cardiovascular disease is notably high among individuals with CKD and type 2 diabetes mellitus (T2D). Sodium-glucose cotransporter...
Saved in:
| Main Authors: | Manisha Sahay, Sunil Prakash, Manik Kataruka, Hardik Shah, Thamburaj Anthuvan, Smriti Gadia, Ashish Prasad, Amit Gupta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-04-01
|
| Series: | Journal of Diabetology |
| Subjects: | |
| Online Access: | https://doi.org/10.4103/jod.jod_200_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress in studies on renal effects and molecular mechanism of SGLT-2 inhibitors
by: XING Bei, et al.
Published: (2020-01-01) -
SGLT2 inhibitors and kidneys: mechanisms and main effects in diabetes mellitus patients
by: Vladimir V Salukhov, et al.
Published: (2021-01-01) -
Increase in urine albumin-to-creatinine ratio as one of the earliest markers of renal damage in patients with hypertension and type 2 diabetes mellitus
by: S.M. Koval, et al.
Published: (2024-06-01) -
Research advances of shrunken pore syndrome
by: Zhang Pei, et al.
Published: (2022-03-01) -
Clinical value of free ubiquitin in the identification of diabetic nephropathy in patients with type 2 diabetes mellitus and preliminary exploration of its protective effect
by: Jing Bian, et al.
Published: (2025-07-01)